| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787630 | Journal of Thoracic Oncology | 2018 | 41 Pages |
Abstract
These findings suggest that the PD-1/PD-L1 pathway is activated in the microenvironment of pulmonary high-grade neuroendocrine carcinoma and correlated with a higher mutation burden.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hye Sook MD, PhD, Jeong Hyeon MD, PhD, Soo Jeong MD, Chan-Young MD, Jae-Woo Moon, Chong Woo MD, PhD, Geon Kook MD, PhD, Ji-Youn MD, PhD,